Document is current
Any future updates will be listed below
-
Authors
Pfarr, Kenneth M.
Krome, Anna K.
Al-Obaidi, Issraa
Batchelor, Hannah
Vaillant, Michel
Hoerauf, Achim
Opoku, Nicholas O.
Kuesel, Annette C.
-
Funding
Funding for this research was provided by:
European and Developing Countries Clinical Trials Partnership (RIA2019PD-2880, RIA2019PD-2880, RIA2019PD-2880, RIA2019PD-2880, RIA2019PD-2880, RIA2019PD-2880, RIA2019PD-2880, RIA2019PD-2880)
Fonds National de la Recherche Luxembourg (FNR n° INTER/EDCTP/19/14338294/MiniMox/Vaillant)
- License Information
-
More Information
Article History
Received: 23 August 2022
Accepted: 5 November 2022
First Online: 1 March 2023
Declarations
:
: Not applicable.
: Not applicable.
: ACK managed the development of moxidectin at WHO TDR.
